Cardiovascular mortality
Continuous positive airway pressure (CPAP) plus best supportive care showed no clear difference in cardiovascular mortality ‐ after 24 months Number of participants:… compared with best supportive care (low certainty).
1 finding from 1 review
RR 1.17 [0.68, 2.02]
Studies not reported
Low
Serious adverse events
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of sleep
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
AHI
1 finding from 1 review
no estimate extracted
Studies not reported
Low
All‐cause mortality ‐ after 24 months Number of participants: 287(2 RCTs)
It is very uncertain whether continuous positive airway pressure (CPAP) plus best supportive care changes all‐cause mortality ‐ after 24 months Number of participants: 287(2… compared with best supportive care (very low certainty).
1 finding from 1 review
RR 1.14 [0.83, 1.56]
Studies not reported
Very low
Time to life‐saving cardiovascular intervention
Continuous positive airway pressure (CPAP) plus best supportive care may leads to lower time to life‐saving cardiovascular intervention ( compared with best supportive care (low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Respiratory failure post extubation · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) probably leads to lower respiratory failure postextubation compared with nasal continuous positive airway pressure (NCPAP) (moderate certainty).
1 finding from 1 review
Reintubation · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) probably leads to lower endotracheal reintubation compared with nasal continuous positive airway pressure (NCPAP) (moderate certainty).
1 finding from 1 review
Gastrointestinal perforation · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in gastrointestinal perforation compared with nasal continuous positive airway pressure (NCPAP) (low certainty).
1 finding from 1 review
Necrotising enterocolitis · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in necrotising enterocolitis compared with nasal continuous positive airway pressure (NCPAP) (moderate certainty).
1 finding from 1 review
Chronic lung disease · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in chronic lung disease (oxygen supplementation at 36 weeks) compared with nasal continuous positive airway pressure (NCPAP) (moderate certainty).
1 finding from 1 review
Pulmonary air leak · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) may leads to lower pulmonary air leak compared with nasal continuous positive airway pressure (NCPAP) (low certainty).
1 finding from 1 review
Mortality before hospital discharge · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in mortality (defined as death before discharge) compared with nasal continuous positive airway pressure (NCPAP) (low certainty).
1 finding from 1 review
Respiratory failure · )
Nasal intermittent positive pressure ventilation (NIPPV) probably leads to lower respiratory failure compared with nasal continuous positive airway pressure (NCPAP) (by population) (moderate certainty).
1 finding from 1 review
Need for endotracheal tube ventilation · )
Nasal intermittent positive pressure ventilation (NIPPV) probably leads to lower need for endotracheal tube ventilation compared with nasal continuous positive airway pressure (NCPAP) (by population) (moderate certainty).
1 finding from 1 review
Death during study period · )
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in mortality during study period compared with nasal continuous positive airway pressure (NCPAP) (by population) (low certainty).
1 finding from 1 review
Chronic lung disease · )
Nasal intermittent positive pressure ventilation (NIPPV) may leads to lower chronic lung disease compared with nasal continuous positive airway pressure (NCPAP) (by population) (low certainty).
1 finding from 1 review
Pneumothorax · )
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in pneumothorax compared with nasal continuous positive airway pressure (NCPAP) (by population) (low certainty).
1 finding from 1 review
Severe (grade 3 or greater) intraventricular hemorrhage (IVH) on cranial ultrasound ‐ not reported · )
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in severe intraventricular hemorrhage (grade III/IV) compared with nasal continuous positive airway pressure (NCPAP) (by population) (low certainty).
1 finding from 1 review